Agilent Technologies Inc (A) reported quarterly earnings results on Monday, May-16-2016. The company said it had a profit of $0.44 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.39. The company posted revenue of $1019.00 million in the period, compared to analysts expectations of $983.35 million. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.38 EPS.
Agilent Technologies Inc closed down -0.11 points or -0.26% at $42.62 with 24,30,565 shares getting traded on Friday. Post opening the session at $42.55, the shares hit an intraday low of $42.39 and an intraday high of $42.93 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on May 12, 2016, Dominique Grau (Senior Vice President) sold 10,322 shares at $43.00 per share price. According to the SEC, on Apr 4, 2016, Heidi Fields (director) sold 30,000 shares at $39.91 per share price. On Mar 21, 2016, Robert J Herbold (director) sold 8,072 shares at $40.30 per share price, according to the Form-4 filing with the securities and exchange commission.
Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.